Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Navitoclax-piperazine | 2143096-93-7 | 99.7% | 973.63 | 1 ML
Supplier: Medchemexpress LLC HY4443210MM/1ML
Navitoclax-piperazine (ABT-263-piperazine) is an analog of Navitoclax and acts as a BCL-XL inhibitor. It serves as the ligand for the target protein of PROTAC DT2216. This compound, when combined with an E3 ubiquitin ligase VHL ligand, can be used to synthesize PROTAC DT2216. PROTACs are compounds that leverage the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
- Analog of Navitoclax
- Acts as a BCL-XL inhibitor
- Serves as a ligand for target proteins
- Can be used in the synthesis of PROTACs
- Utilizes the ubiquitin-proteasome system for selective protein degradation
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?